Jurij Młynk

Recent publications · Crossref

5 total works indexed

1. Epidemic thresholds in real networks

   · 2008 · cited 564x

2. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

   · 2017 · cited 503x

3. Synthesis of Heterocycles from Alkyl 3-(Dimethylamino)propenoates and Related Enaminones

   · 2004 · cited 485x

4. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

   · 2018 · cited 471x

5. Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

   · 2008 · cited 417x

via Crossref · CC0